Caroline V Magnain, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 9 | 2023 | 2917 | 0.930 |
Why?
|
| Microscopy | 3 | 2023 | 903 | 0.670 |
Why?
|
| Nissl Bodies | 1 | 2018 | 16 | 0.640 |
Why?
|
| Holography | 2 | 2014 | 80 | 0.540 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1085 | 0.540 |
Why?
|
| Temporal Lobe | 2 | 2018 | 1695 | 0.430 |
Why?
|
| Lasers | 3 | 2022 | 952 | 0.410 |
Why?
|
| Microvessels | 2 | 2022 | 577 | 0.390 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1496 | 0.370 |
Why?
|
| Subtraction Technique | 1 | 2013 | 512 | 0.360 |
Why?
|
| Neurons | 3 | 2022 | 9463 | 0.330 |
Why?
|
| Aniline Compounds | 1 | 2013 | 1069 | 0.300 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2220 | 0.300 |
Why?
|
| Pigmentation | 1 | 2008 | 144 | 0.300 |
Why?
|
| Molecular Imaging | 1 | 2014 | 815 | 0.290 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 277 | 0.260 |
Why?
|
| Blood | 1 | 2008 | 596 | 0.250 |
Why?
|
| Brain | 11 | 2023 | 27120 | 0.230 |
Why?
|
| Algorithms | 5 | 2022 | 14032 | 0.230 |
Why?
|
| Image Enhancement | 1 | 2013 | 2885 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 3359 | 0.180 |
Why?
|
| Histological Techniques | 2 | 2022 | 193 | 0.170 |
Why?
|
| Myelin Sheath | 2 | 2022 | 653 | 0.170 |
Why?
|
| Trigeminal Nerve | 1 | 2021 | 248 | 0.160 |
Why?
|
| Dura Mater | 1 | 2021 | 290 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2022 | 4063 | 0.160 |
Why?
|
| Cerebral Arteries | 1 | 2021 | 490 | 0.150 |
Why?
|
| Skin | 2 | 2008 | 4484 | 0.140 |
Why?
|
| Color | 2 | 2008 | 299 | 0.140 |
Why?
|
| Oxygen | 1 | 2008 | 4227 | 0.140 |
Why?
|
| Microscopy, Polarization | 1 | 2016 | 89 | 0.130 |
Why?
|
| Fundus Oculi | 2 | 2014 | 556 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3575 | 0.120 |
Why?
|
| Interferometry | 1 | 2014 | 100 | 0.120 |
Why?
|
| Scattering, Radiation | 2 | 2022 | 490 | 0.110 |
Why?
|
| Cerebral Cortex | 2 | 2023 | 5779 | 0.110 |
Why?
|
| Headache | 1 | 2021 | 1256 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 9002 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 20099 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 256 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2013 | 960 | 0.080 |
Why?
|
| Ophthalmoscopy | 1 | 2010 | 171 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2400 | 0.080 |
Why?
|
| Melanosomes | 1 | 2008 | 33 | 0.080 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2008 | 119 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2013 | 863 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 957 | 0.070 |
Why?
|
| Optics and Photonics | 1 | 2008 | 306 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 15266 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 888 | 0.060 |
Why?
|
| Lipofuscin | 1 | 2023 | 40 | 0.060 |
Why?
|
| Brain Mapping | 2 | 2023 | 6635 | 0.060 |
Why?
|
| Rats | 2 | 2014 | 23741 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 36429 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2014 | 6241 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2008 | 2413 | 0.040 |
Why?
|
| Humans | 14 | 2023 | 761572 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14666 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20571 | 0.040 |
Why?
|
| Aged | 4 | 2022 | 169310 | 0.040 |
Why?
|
| Cadaver | 1 | 2022 | 1358 | 0.040 |
Why?
|
| Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
| Uncertainty | 1 | 2021 | 754 | 0.030 |
Why?
|
| Male | 6 | 2022 | 360842 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8711 | 0.030 |
Why?
|
| Middle Aged | 3 | 2022 | 220920 | 0.030 |
Why?
|
| Entropy | 1 | 2014 | 210 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 369 | 0.030 |
Why?
|
| Antimutagenic Agents | 1 | 2013 | 6 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2526 | 0.030 |
Why?
|
| Mice | 3 | 2016 | 81533 | 0.030 |
Why?
|
| Cobalt | 1 | 2013 | 154 | 0.030 |
Why?
|
| Female | 5 | 2022 | 392686 | 0.030 |
Why?
|
| Hypoxia, Brain | 1 | 2013 | 138 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9469 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 502 | 0.020 |
Why?
|
| Adult | 3 | 2022 | 221203 | 0.020 |
Why?
|
| Animals | 4 | 2016 | 168467 | 0.020 |
Why?
|
| Gadolinium | 1 | 2014 | 960 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2850 | 0.020 |
Why?
|
| Head | 1 | 2014 | 924 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2013 | 751 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58986 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2014 | 1769 | 0.020 |
Why?
|
| Artifacts | 1 | 2014 | 1911 | 0.020 |
Why?
|
| Angiography | 1 | 2010 | 1595 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5872 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5247 | 0.010 |
Why?
|
| Retina | 1 | 2010 | 2659 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3980 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 18965 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 22172 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18253 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 9031 | 0.010 |
Why?
|